Aggression and schizophrenia: Efficacy of risperidone

Journal of the American Academy of Psychiatry and the Law

Volumn 25, Issue 2, 1997, Pages 173-181

  Buckley, Peter F ^a   Ibrahim, Zafar Y ^a   Singer, Beth ^a   Orr, Bruce ^a   Donenwirth, Karl ^a   Brar, Parminder S ^a  

^a ODMH Northcoast Behavioral Healthcare   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; RISPERIDONE;

ADULT; AGGRESSIVENESS; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; MALE; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA;

ADULT; AGGRESSION; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OHIO; PSYCHOPHARMACOLOGY; RESTRAINT, PHYSICAL; RETROSPECTIVE STUDIES; RISPERIDONE; SCHIZOPHRENIA; SOCIAL ISOLATION; TREATMENT OUTCOME;

EID: 0031408761     PISSN: 10936793     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Buckley PF, Walshe D, Colohan H, et al.: Violence and schizophrenia: a study of the occurrence and clinical correlates of violence among schizophrenia patients. Ir J Psychol Med 7:102-8, 1990
2. Corrigan PW, Yudosfsky SC, Silver JM: Pharmacological and behavioral treatments for aggressive psychiatric inpatients. Hosp Community Psychiatry 44:125-33, 1993
3. Schulz SC, Buckley PF: Treatment resistant schizophrenia, in Schizophrenia. Edited by Hirsch SR and Weinberger DR. London: Blackwell Publications, 1995
4. Hirsch SR, Barnes TRE: Clinical use of high-dose neuroleptics. Br J Psychiatry 164:94-6, 1994
5. Christison GW, Kirch DG, Wyatt RJ: When symptoms persist: choosing among alternative somatic treatments for schizophrenia. Schizophr Bull 17:217-45, 1991
6. Buckley PF, Bartell J, Donenwirth K, Lee S, Torigoe F, Schulz SC: Violence and schizophrenia: clozapine as a specific anti-aggressive agent. Bull Am Acad Psychiatry Law 23:607-11, 1995
7. Kane J, Honigfeld G, Singer J, et al.: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789-96, 1988
8. Kane JM: Schizophrenia. N Engl J Med 334: 34-9, 1996
9. Wilson WH, Claussen AM: 18-month outcome of clozapine treatment for 100 patients in a state psychiatric hospital. Hosp Community Psychiatry 46:386-9, 1995
10. Reid WH, Mason M, Toprac M: Savings in hospital bed-days related to treatment with clozapine. Hosp Community Psychiatry 45: 261-4, 1994
11. Maier GJ: The impact of clozapine on 25 forensic patients. Bull Am Acad Psychiatry Law 20:247-307, 1992
12. Wilson WH: Clinical review of clozapine treatment in state hospital. Hosp Community Psychiatry 43:700-03, 1992
13. Ratey JN, Leveron C, Kilmer D, et al.: The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital. J Clin Psychiatry 54:219-23, 1993
14. Michals ML, Crismon ML, Roberts S, Childs A: Clozapine response and adverse effects in nine brain-injured patients. J Clin Psychopharmacol 13:198-203, 1993
15. Volavka J, Zito J, Vitra J, Czobor P: Clozapine effects on hostility and aggression in schizophrenia. J Clin Psychopharmacol 13: 287-9, 1993
16. Chiles J, Davidson P, McBride D: Effects of clozapine on use of seclusion and restraint in a state hospital. Hosp Community Psychiatry 45:269-71, 1994
17. Ebrahim G, Gibler B, Gacano CB, Hayes G: Patient response to clozapine in a forensic psychiatric hospital. Hosp Community Psychiatry 45:271-3, 1994
18. Frankenburg FR, Zanarini MC: Clozapine treatment of borderline patients: a preliminary study. Compr Psychiatry 34:402-5, 1993
19. Marder SR, Meibach RC: Risperidone in the treatment of schizophrenia. Am J Psychiatry 151:825-35, 1994
20. Pickar D: Serotonin and dopamine abnormalities in schizophrenia. J Clin Psychiatry 12: 10-2, 1994
21. Chouinard G, Jones B, Remington G, et al.: A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 13: 25-40, 1993
22. Hoyberg OJ, Fensbo C, Remvig J, Lingjaerde O, Sloth-Nielsen M, Salvesen I: Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations. Acta Psychiatr Scand 88:395-402, 1993
23. Peuskens J, on behalf of the Risperidone Study Group: Risperidone in the treatment of patients with chronic schizophrenia: a multinational, multicentre, double-blind, parallel-group study versus haloperidol. Br J Psychiatry 166:712-26, 1995
24. Claus A, Bollen J, DeCuyper H, et al.: Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study. Acta Psychiatr Scand 85:295-305, 1992
25. Kronig MH, Loebel AD, Mendelowitz A, et al.: Risperidone for treatment refractory schizophrenia. Presented at the 150th Annual Meeting of the American Psychiatric Association, Philadelphia, PA, May 1994
26. Klieser E, Lehmann E, Kinzler E, Wurthmann C, Heinrich K: Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia. J Clin Psychopharmacol 15:455-515, 1995
27. Bondolfi G, Bauman P, Petris M, May JP, Billeter U, Defour H: A randomized double-blind trial of risperidone versus clozapine for treatment-resistant chronic schizophrenia. Presented at the 151st Annual Meeting of the American Psychiatric Association, Miami, FL, May 1995
28. Keck PE, Wilson DR, Strakowski SM, et al.: Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder and psychotic mood disorders. J Clin Psychiatry 56:466-70, 1995
29. Negron AE, Liederman EA, Parkadavil M, Cienfuegos A, Javitt DC: Risperidone treatment in an academic state hospital setting: a retrospective study of outcome. Presented at the 152nd Annual Meeting of the American Psychiatric Association, New York, May 5-9, 1996
30. Buckley PF, Donenwirth K, Bayer KE, Lys C, Ibrahim ZY, Schulz SC: Risperidone treatment of schizophrenia in a state hospital. Schizophr Res 15:145, 1995
31. Czobor P, Volavka J, Meibach RC: Effect of risperidone on hostility in schizophrenia. J Clin Psychopharmacol 15:243-9, 1995
32. Jeanblanc W, Davis YB: Risperidone for treating dementia-associated aggression. Am J Psychiatry 152:1239, 1995
33. Davis JM: Comparative doses and costs of antipsychotic medication. Arch Gen Psychiatry 33:858-61, 1976
34. Fisher WA: Restraint and seclusion: a review of the literature. Am J Psychiatry 151:1584, 1994